Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy

S Ramesh, M Govindarajulu, RS Parise, L Neel… - Vaccines, 2021 - mdpi.com
The widespread increase in multiple severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) variants is causing a significant health concern in the United States and …

Biological properties of SARS-CoV-2 variants: epidemiological impact and clinical consequences

R Hoteit, HM Yassine - Vaccines, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that belongs to
the coronavirus family and is the cause of coronavirus disease 2019 (COVID-19). As of May …

Second wave of COVID-19 in Brazil: younger at higher risk

FSH de Souza, NS Hojo-Souza, CM da Silva… - European journal of …, 2021 - Springer
The Brazilian Amazon region was severely affected by the COVID-19 epidemic, which
started in March 2020. After a cases and deaths peak in May 2020, a study conducted by …

COVID-19: epidemiology and mutations: An update

CJ Hemmer, M Löbermann, EC Reisinger - Der Radiologe, 2021 - Springer
Mutationen von SARS-CoV‑2 können die Ausbreitungsfähigkeit und Infektiosität erhöhen
sowie die Schutzwirkung von Antikörpern vermindern, die nach einer Infektion, einer …

Severe acute respiratory syndrome coronavirus 2 variants of concern: a perspective for emerging more transmissible and vaccine-resistant strains

AS de Souza, VM de Freitas Amorim, GDA Guardia… - Viruses, 2022 - mdpi.com
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern
(VOC) are constantly threatening global public health. With no end date, the pandemic …

Young adults vulnerability to COVID-19 in Brazil: an overview across the country

FSH de Souza, NS Hojo-Souza, DCR de Oliveira… - medRxiv, 2021 - medrxiv.org
Brazil is a country of continental dimensions, where many smaller countries would fit. In
addition to demographic, socioeconomic, and cultural differences, hospital infrastructure and …

[HTML][HTML] Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases

E Bonfa, A Medeiros-Ribeiro, N Aikawa, C Saad… - 2021 - europepmc.org
Abstract CoronaVac (SARS-CoV-2 inactivated vaccine) has been largely used as the main
immunogen for COVID-19 in several countries. However, its immunogenicity in …

[HTML][HTML] The Role of Serology in Tracking COVID-19 Mutations

A Lane - clpmag.com
The Role of Serology in Tracking COVID-19 Mutations | Clinical Lab Products Clinical Lab
Products Diagnostic Technologies Anatomic Pathology Clinical Chemistry Digital Pathology Flow …